
Abortion pill manufacturer sues FDA to preserve access and protect drug.
GenBioPro, the manufacturer of generic mifepristone, has sued the FDA to prevent the drug from being removed from the market. The lawsuit comes on the day that the Supreme Court is expected to rule on whether restrictions should be imposed on the drug, including potentially revoking the generic version's FDA authorization. The company is seeking an order that would require the FDA to keep GenBioPro's mifepristone on the market.



